CAS: 201605-51-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-2-oxoethyl]-, (βR)- REF: IN-DA002DJ5CAS: 201605-51-8 | 98% | To inquire | Tue 07 Jan 25 | |
Itriglumide REF: TM-T27640CAS: 201605-51-8 | 99.95% | 272.00 €~1,836.00 € | Mon 24 Feb 25 |
1-Naphthalenepropanoic acid, β-[2-[[2-(8-azaspiro[4.5]dec-8-ylcarbonyl)-4,6-dimethylphenyl]amino]-2-oxoethyl]-, (βR)-
CAS:201605-51-8
Formula:
C33H38N2O4
Purity:
98%
Molecular weight:
526.6658
Ref: IN-DA002DJ5
1mg | 527.00 € | ||
2mg | 559.00 € | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Itriglumide
CAS:201605-51-8
Itriglumide, a CCK2 receptor antagonist, is used potentially for the treatment of peptic ulcers, dyspepsia, …
Formula:
C33H38N2O4
Purity:
99.95%
Color and Shape:
Solid
Molecular weight:
526.67
Ref: TM-T27640
1mg | 272.00 € | ||
2mg | 405.00 € | ||
5mg | 670.00 € | ||
10mg | 915.00 € | ||
25mg | 1,409.00 € | ||
50mg | 1,836.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025